However, there was no significant correlation between lncRNA CBR3-AS1 expression and tumor differentiation (poor vs well OR = 1.71, 95% CI:1.00–2.92, P = .05), age (old vs young OR = 1.08, 95% CI:0.77–1.51, P = .67) and gender (male vs female OR = 1.26, 95% CI:0.84–1.89, P = .25) (Figure S1, Supplemental Digital Content, http://links.lww.com/MD/N895). The gene discussed is CBR3; the disease is neoplasm.